ARCpoint Inc. (TSXV:ARC)

Market Cap	12.90M
Revenue (ttm)	8.53M
Net Income (ttm)	-722.68K
Shares Out	128.97M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6,400
Open	0.1000
Previous Close	0.1000
Day's Range	0.1000 - 0.1000
52-Week Range	0.0400 - 0.1500
Beta	-1.92
RSI	64.58
Earnings Date	Apr 11, 2025

About ARCpoint

ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. The company operates in two segments, ARCpoint Franchise and AFG Services. It offers clinical healthcare; viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing and screening; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient d...

• Industry: Other
• Founded: 1998
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: ARC

Financial Performance

In 2023, ARCpoint's revenue was $6.67 million, a decrease of -38.73% compared to the previous year's $10.88 million. Losses were -$8.66 million, 7.74% more than in 2022.

Financial numbers in USD